Skip to main content
IFF
NYSE Industrial Applications And Services

IFF Q3 Sales Rise 4% to $1.94B; Full-Year Guidance Low End Raised

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
7
Price
$92.18
Mkt Cap
$23.52B
52W Low
$61.295
52W High
$95.27
52W Position info
50% above low
Off High info
3.2% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

IFF sits 50% above its 52-week low of $61.295.

Summary

IFF grew third-quarter sales 4% to $1.94 billion and adjusted EBITDA 6% currency neutral, then raised the low end of its 2026 guidance. Disposal-related charges drove the GAAP loss, and management warned of a softer fourth quarter in Health & Biosciences.


Key Events · Earnings and Guidance · IFF

  • Q3 Sales Grow 4% to $1.94B

    Reported net sales were $1.94 billion, up 4% versus the prior year and 5% currency neutral, with Taste up 6%, Scent up 6% and Health & Biosciences up 1% on a comparable currency neutral basis.

  • Adjusted EBITDA $403M at 20.8% Margin

    Adjusted operating EBITDA was $403 million, up 6% currency neutral, with segment margins of 18.6% in Taste, 24.0% in Health & Biosciences and 20.2% in Scent.

  • GAAP Loss Driven by Disposal Charges

    The $(134) million loss before taxes and $(0.50) diluted EPS include a $236 million loss on assets classified as held for sale and $34 million of regulatory costs; adjusted EPS ex-amortization was $0.83.

  • Full-Year Guidance Low End Raised

    2026 sales guidance is now $7.5-7.6 billion (from $7.4-7.6 billion) and adjusted operating EBITDA $1.55-1.60 billion (from $1.53-1.60 billion), with currency neutral EBITDA growth of 5-8%.


Analysis · IFF · Industrial Applications And Services

The underlying business is working: sales rose 4% to $1.94 billion and adjusted operating EBITDA reached $403 million at a 20.8% margin, up 6% currency neutral, with all three divisions growing. The GAAP loss of $134 million before taxes and $(0.50) per share stems from a $236 million loss on assets classified as held for sale tied to the Botanicals & Food Enhancements and CitraSource disposals, not from operations. Management raised the low end of full-year sales and EBITDA guidance, but flagged softer fourth-quarter profitability, particularly in Health & Biosciences, on higher costs and reinvestment. The $500 million accelerated share repurchase is complete, and the Food Ingredients divestiture remains on track to close by the end of the second quarter of 2027.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, IFF was trading at $92.18 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $23.5B. The 52-week trading range was $61.30 to $95.27. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

IFF - Latest Insights

IFF
Nov 04, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $89.00
Real-time Price: $79.62 info
Change: -$9.38 (-11%) info
Market Cap: $19.939B info
IFF
Nov 03, 2026, 4:31 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $92.18
Real-time Price: $79.62 info
Change: -$12.56 (-14%) info
Market Cap: $19.939B info
IFF
Nov 03, 2026, 4:15 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $92.18
Real-time Price: $79.62 info
Change: -$12.56 (-14%) info
Market Cap: $19.939B info
IFF
Aug 04, 2026, 6:32 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $81.00
Real-time Price: $79.62 info
Change: -$1.38 (-2%) info
Market Cap: $19.939B info
IFF
Aug 04, 2026, 4:40 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $81.00
Real-time Price: $79.62 info
Change: -$1.38 (-2%) info
Market Cap: $19.939B info